🗓️Apertura ene/27
🔹IHI Call 14 (single)-> 4 topics #NAMs #PersonalisedHealthTech #PatientCare #ATMPs
🔹IHI Call 15 (two-stage)->2 topics #CompassionateUse, #SurrogateEndpoints
🔗 www.horizonteeuropa.es/publicacion-...
@horizonteeuropa.bsky.social
🗓️Apertura ene/27
🔹IHI Call 14 (single)-> 4 topics #NAMs #PersonalisedHealthTech #PatientCare #ATMPs
🔹IHI Call 15 (two-stage)->2 topics #CompassionateUse, #SurrogateEndpoints
🔗 www.horizonteeuropa.es/publicacion-...
@horizonteeuropa.bsky.social
👉 www.ihi.europa.eu/news-events/...
❗Be aware: these are drafts. Always consult the final texts!
#HorizonEU #ResearchFunding
👉 www.ihi.europa.eu/news-events/...
❗Be aware: these are drafts. Always consult the final texts!
#HorizonEU #ResearchFunding
www.nice.org.uk/news/article...
RCTs in #nephrology #longtime #surrogateendpoints need to predict the clinical endpoint👆🏻 #eraedta19 @ERAEDTA @ynptweets @fjcaskey
RCTs in #nephrology #longtime #surrogateendpoints need to predict the clinical endpoint👆🏻 #eraedta19 @ERAEDTA @ynptweets @fjcaskey
www.bmj.com/content/386/... (CONSORT-SURROGATE)
www.bmj.com/content/386/... (SPIRIT-SURROGATE)
#statsSky #reporting #clinicaltrials #surrogateendpoints #transparency #
www.bmj.com/content/386/... (CONSORT-SURROGATE)
www.bmj.com/content/386/... (SPIRIT-SURROGATE)
#statsSky #reporting #clinicaltrials #surrogateendpoints #transparency #
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints